The Potential Role of Advanced Glycation End Products in the Development of Kidney Disease
Nutrients · 21.02.2025 · 17 (5) · 758
DOI: 10.3390/nu17050758 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 21.02.2025. Verfasst von Yibin Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, School of Public Health, Tongji Medical College, Huazhon…. Hauptthemen laut MEDLINE: Glycation End Products, Advanced, Kidney Diseases. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Advanced glycation end products (AGEs) represent a class of toxic and irreversible compounds formed through non-enzymatic reactions between proteins or lipids and carbonyl compounds. AGEs can arise endogenously under normal metabolic conditions and in pathological states such as diabetes, kidney disease, and inflammatory disorders. Additionally, they can be obtained exogenously through dietary intake, particularly from foods high in fat or sugar, as well as grilled and processed items. AGEs accumulate in various organs and have been increasingly recognized as significant contributors to the progression of numerous diseases, particularly kidney disease. As the kidney plays a crucial role in AGE metabolism and excretion, it is highly susceptible to AGE-induced damage. In this review, we provide a comprehensive discussion on the role of AGEs in the onset and progression of various kidney diseases, including diabetic nephropathy, chronic kidney disease, and acute kidney injury. We explore the potential biological mechanisms involved, such as AGE accumulation, the AGEs-RAGE axis, oxidative stress, inflammation, gut microbiota dysbiosis, and AGE-induced DNA damage. Furthermore, we discuss recent findings on the metabolic characteristics of AGEs in vivo and their pathogenic impact on renal function. Additionally, we examine the clinical significance of AGEs in the early diagnosis, treatment, and prognosis of kidney diseases, highlighting their potential as biomarkers and therapeutic targets. By integrating recent advancements in AGE research, this review aims to provide new insights and strategies for mitigating AGE-related renal damage and improving kidney disease management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
- Ministry of Education Key Laboratory of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
ORCID-Profile: Lei King, Liegang Liu
Zitieren
APA
Ma, Y., Wang, X., Lin, S., King, L., & Liu, L. (2025). The Potential Role of Advanced Glycation End Products in the Development of Kidney Disease. Nutrients, 17(5), 758. https://doi.org/10.3390/nu17050758
Vancouver
Ma Y, Wang X, Lin S, King L, Liu L. The Potential Role of Advanced Glycation End Products in the Development of Kidney Disease. Nutrients. 2025;17(5):758. doi:10.3390/nu17050758
BibTeX
@article{Ma2025,
author = {Ma, Yibin and Wang, Xinyu and Lin, Shan and King, Lei and Liu, Liegang},
title = {The Potential Role of Advanced Glycation End Products in the Development of Kidney Disease},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {5},
pages = {758},
doi = {10.3390/nu17050758}
}
EUVIMED